Data as of Aug 27
| -0.28 / -1.11%|
The 8 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 31.50, with a high estimate of 33.00 and a low estimate of 23.00. The median estimate represents a +25.85% increase from the last price of 25.03.
The current consensus among 8 polled investment analysts is to Buy stock in PharMerica Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.